Christina Rossi
Chief Operating Officer at BLUEPRINT MEDICINES CORPORATION
Net worth: 3 M $ as of 2024-05-30
Christina Rossi active positions
| Companies | Position | Start | End |
|---|---|---|---|
| BLUEPRINT MEDICINES CORPORATION | Chief Operating Officer | 2022-04-03 | - |
| Corporate Officer/Principal | 2018-10-28 | 2022-04-03 | |
| XILIO THERAPEUTICS, INC. | Director/Board Member | 2021-03-31 | - |
| Independent Dir/Board Member | 2021-03-31 | - |
Career history of Christina Rossi
Former positions of Christina Rossi
| Companies | Position | Start | End |
|---|---|---|---|
Genzyme Corp.
 Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2011-12-31 | 2018-09-30 |
Eidetica Biopharma GmbH
 Eidetica Biopharma GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Eidetica Biopharma GmbH is a Swiss company that develops and manufactures biopharmaceutical drugs. The company is based in Zug, Switzerland. | Corporate Officer/Principal | 2004-12-31 | 2009-12-31 |
Training of Christina Rossi
| Duke University | Undergraduate Degree |
| Harvard Business School | Masters Business Admin |
Statistics
International
| United States | 6 |
| Switzerland | 2 |
Operational
| Corporate Officer/Principal | 3 |
| Chief Operating Officer | 1 |
| Undergraduate Degree | 1 |
Sectoral
| Health Technology | 5 |
| Consumer Services | 3 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 2 |
|---|---|
| BLUEPRINT MEDICINES CORPORATION | Health Technology |
| XILIO THERAPEUTICS, INC. | Health Technology |
| Private companies | 2 |
|---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Eidetica Biopharma GmbH
Eidetica Biopharma GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Eidetica Biopharma GmbH is a Swiss company that develops and manufactures biopharmaceutical drugs. The company is based in Zug, Switzerland. | Health Technology |
- Stock Market
- Insiders
- Christina Rossi
- Experience
